—

BioNTech SE(BNTX)— 同業公司組

數據截至2026-11-20 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

BioNTech SE的Closelook綜合評分為35/100,在同業公司組內排名第16位(共16家)——組內評分最高的是Halozyme Therapeutics Inc(72/100)。

名稱綜合動能品質估值訊號距52週高點
BNTX BioNTech SE35342354bear34.4%
ASML.AS ASML Holding N.V.66428734bear26%
TEMN.SW Temenos Group AG64758938bull11.4%
SGE.L Sage Group PLC63878350bull6.3%
SAN.PA Sanofi SA63756962bull5.9%
WKL.AS Wolters Kluwer N.V.62918363bull25%
CEVI.ST CellaVision AB61967226bull1.4%
REL.L Relx PLC61858452bull16.3%
SAP.DE SAP SE61797633bear22.1%
SECT-B.ST Sectra AB (publ)61906710bull2.8%
PATH Uipath Inc60455851bear43.4%
OXIG.L Oxford Instruments PLC58446151bear23%
DSY.PA Dassault Systemes SE57777438neutral23.9%
HALO Halozyme Therapeutics Inc72679451info31.8%
ONC BeOne Medicines AG66886829ok8%
REGN Regeneron Pharmaceuticals Inc65897346watch7%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-11-20

Quick answers

BioNTech SE在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:ASML Holding N.V. (ASML.AS)、Temenos Group AG (TEMN.SW)、Sage Group PLC (SGE.L)、Sanofi SA (SAN.PA)、Wolters Kluwer N.V. (WKL.AS)、CellaVision AB (CEVI.ST)、Relx PLC (REL.L)、SAP SE (SAP.DE)等。

BNTX相對同業公司的評分如何?

BioNTech SE的綜合評分為35/100,組內排名第16位(共16家),截至2026-11-20;組內最高綜合評分為Halozyme Therapeutics Inc(72/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.